Evidence map›Paper›PMID 41206418›Full record

ArticleMolecular psychiatry2026

Prefrontal circHomer1 regulates synaptic and behavioral adaptations induced by cocaine.

Yun Chen, Zhongyu Zhang, Xianfeng Li, Wenjun Chen, Shihao Huang, Guipeng Zhang, Zhoulong Yu, Libo Zhang, Shiqiu Meng, Jianfeng Liu and 2 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yun Chen *National Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China.ORCID 0000-0001-8058-1236
Zhongyu Zhang *National Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China.
Xianfeng LiDepartment of Gastroenterology of Daping Hospital, Third Military Medical University, Chongqing, 400042, China.
Wenjun ChenNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China.
Shihao HuangNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China.
Guipeng ZhangNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China.
Zhoulong YuNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China.
Libo ZhangNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China.ORCID 0000-0002-6829-1452
Shiqiu MengNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China.
Jianfeng LiuBrain Science and Advanced Technology Institute, Wuhan University of Science and Technology, Wuhan, Hubei, 430081, China.
Yan-Xue XueNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China. yanxuexue@bjmu.edu.cn.ORCID 0000-0003-2979-0045
Jie ShiNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing, 100191, China. shijie@bjmu.edu.cn.ORCID 0000-0001-6567-8160

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32161143022National Natural Science Foundation of China (National Science Foundation of China) 82130040National Natural Science Foundation of China (National Science Foundation of China) 82288101
6 · The paper itself

Abstract

Substance use disorder (SUD) represents a substantial challenge in neuropsychiatric medicine, with the molecular mechanisms underlying its etiology remaining elusive. The molecular underpinnings of SUD suggest a pivotal role for circular RNAs (circRNAs) in its pathophysiology. Herein, we present a study on circHomer1, a circRNA enriched in neurons, which is abnormal expression upon cocaine exposure. Employing models of repeated cocaine exposure and conditioning place preference (CPP), alongside virus-mediated gene regulation techniques, we revealed the contribution of circHomer1 in cocaine-induced rewarding effects and synaptic adaptations. We found a notably downregulation of circHomer1 expression in the prelimbic cortex consequent to repeated cocaine exposure in both rat model and patients with cocaine use disorder. Elevation of circHomer1 levels resulted in a pronounced attenuation of cocaine-induced CPP, whereas suppression of circHomer1 expression enhanced the rewarding effects. These outcomes were specifically observed in excitatory neurons, implicating a cell type-specific function of circHomer1. Furthermore, the restoration of circHomer1 rescued the reduction of mushroom-type dendritic spines and rectified deficits in the frequency of spontaneous excitatory postsynaptic currents associated with prolonged cocaine exposure. Mechanistically, circHomer1 appears to modulate cocaine-induced behavioral responses through dopamine D1 receptor signaling pathways. Notably, circHomer1's behavioral effects showed specificity for psychostimulants (cocaine and methamphetamine), without affecting food- or opioid-associated rewards. Our findings highlight the significant role of circHomer1 in regulating cocaine reward and identify a novel molecular regulator of the actions of cocaine on the brain's reward circuitry, providing a new strategy for treating drug addiction.

Indexed as

CocaineAnimalsBehavior, AnimalCocaine-Related DisordersDendritic SpinesDisease Models, AnimalExcitatory Postsynaptic PotentialsHumansMaleNeuronsPrefrontal CortexRatsRats, Sprague-DawleyReceptors, Dopamine D1RewardSynapsesCocaineReceptors, Dopamine D1

Identifiers

PMID41206418
PMCPMC12916321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.